AI assistant
LTR PHARMA LIMITED — Capital/Financing Update 2023
Dec 6, 2023
65273_rns_2023-12-06_70694a4d-8c90-44ae-b11d-5491e33e7350.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Market Announcement
==> picture [33 x 50] intentionally omitted <==
7 December 2023
==> picture [451 x 5] intentionally omitted <==
LTR Pharma Limited (ASX: LTP) – Admission and Quotation
Description
LTR Pharma Limited (‘LTP’) was admitted to the Official List of ASX on Thursday, 7 December 2023.
The securities of LTP will commence quotation at 11:00 AM AEDT on Monday, 11 December 2023.
LTP raised $7,000,000 pursuant to the offer under its replacement prospectus dated 9 November 2023 by the issue of 35,000,000 shares at an issue price of $0.20 per share.
Quotation information
| Quoted securitiesFully paid ordinary shares: 70,405,488ASX codeFully paid ordinary shares: LTPTime11:00 AM AEDTDateMonday, 11 December 2023ASX trade abbreviationLTR PHARMAISINFully paid ordinary shares: AU0000305294Registered officeAddress: 9/204 Alice Street, Brisbane, Queensland 4000 | Quoted securitiesFully paid ordinary shares: 70,405,488ASX codeFully paid ordinary shares: LTPTime11:00 AM AEDTDateMonday, 11 December 2023ASX trade abbreviationLTR PHARMAISINFully paid ordinary shares: AU0000305294Registered officeAddress: 9/204 Alice Street, Brisbane, Queensland 4000 | Quoted securitiesFully paid ordinary shares: 70,405,488ASX codeFully paid ordinary shares: LTPTime11:00 AM AEDTDateMonday, 11 December 2023ASX trade abbreviationLTR PHARMAISINFully paid ordinary shares: AU0000305294Registered officeAddress: 9/204 Alice Street, Brisbane, Queensland 4000 | Quoted securitiesFully paid ordinary shares: 70,405,488ASX codeFully paid ordinary shares: LTPTime11:00 AM AEDTDateMonday, 11 December 2023ASX trade abbreviationLTR PHARMAISINFully paid ordinary shares: AU0000305294Registered officeAddress: 9/204 Alice Street, Brisbane, Queensland 4000 | Quoted securitiesFully paid ordinary shares: 70,405,488ASX codeFully paid ordinary shares: LTPTime11:00 AM AEDTDateMonday, 11 December 2023ASX trade abbreviationLTR PHARMAISINFully paid ordinary shares: AU0000305294Registered officeAddress: 9/204 Alice Street, Brisbane, Queensland 4000 | Quoted securitiesFully paid ordinary shares: 70,405,488ASX codeFully paid ordinary shares: LTPTime11:00 AM AEDTDateMonday, 11 December 2023ASX trade abbreviationLTR PHARMAISINFully paid ordinary shares: AU0000305294Registered officeAddress: 9/204 Alice Street, Brisbane, Queensland 4000 | Quoted securitiesFully paid ordinary shares: 70,405,488ASX codeFully paid ordinary shares: LTPTime11:00 AM AEDTDateMonday, 11 December 2023ASX trade abbreviationLTR PHARMAISINFully paid ordinary shares: AU0000305294Registered officeAddress: 9/204 Alice Street, Brisbane, Queensland 4000 |
|---|---|---|---|---|---|---|
| Phone: 1800 519 711Email: investors@ltrpharmacom | ||||||
| Company secrShare Registry | . | |||||
| etaryBelind | a Cleminson | |||||
| AutoAddrePhon | mic Pty Ltdss: 477 Collins St, Melbo: +61 (0)2 9698 5414 | urne VIC 30 | 00 | |||
| Balance date | : [email protected] | |||||
| 30 Ju | e | |||||
| CHESS | ||||||
| Partic | ipating. CHESS and Issuer | Sponsored | ||||
| Place of incorpDividend polic | orationAustr | alia | ||||
| ySee s | ection 7.11 of the Replace | ment Pros | pectus | |||
| Activities | Drughealtdema | development, research ah and, currently, commernd therapeutic nasal spra | nd repurpocialising a 'fy for the tr | sing compairst-in-claseatment of | ny, focuses' rapid onserectile dy | d on men’set, onsfunction. |
| Lead managerUnderwriter | Alpin | e Capital Pty Ltd | ||||
| N/A | ||||||
| ASX restricted | tedng 24 | |||||
| securities69,01securi | 4,764 fully paid ordinaryties and to be held in esc | shares clasrow until 1 | sified by AS1 Decembe | X as restricr 2025, bei | ||
| months from the date of Quotation. |
Market Announcement 1/2 ASX Customer Service Centre 131 279 | asx.com.au
7 December 2023 ASX Limited
#10666041v3
==> picture [33 x 50] intentionally omitted <==
2,792,344 options exercisable at $0.26 on or before 11 December 2026, classified by ASX as restricted securities and to be held in escrow until 11 December 2025, being 24 months from the date of Quotation. 2,000,000 options exercisable at $0.22 on or before 11 December 2028, classified by ASX as restricted securities and to be held in escrow until 11 December 2025, being 24 months from the date of Quotation. Other securities not quoted N/A
What do I need to do and by when?
For further information, please refer to LTP’s Replacement Prospectus.
Need more information?
For further information, please call the IPO information line on 1300 441 607 (within Australia) or +61 2 7250 6677 (outside Australia) from 9.00am until 5.00pm AEDT Monday to Friday.
Disclaimer
Please refer to the following disclaimer.
Issued by
ASX Compliance
Market Announcement 2/2
7 December 2023
#10666041v3